#PsychiatryStudy

A Brazilian study suggests cannabidiol (CBD) may help ease autism symptoms in children and young adults. Researchers from the University of São Paulo reported that oral CBD led to improvements in social skills, fewer tantrums, and reduced aggression in participants. Presented at the 2025 European Congress of Psychiatry, the findings indicate CBD could complement traditional therapies, though experts urge larger trials to confirm results.

Interest in CBD arises from its role in supporting the body’s endocannabinoid system, which influences mood and stress. Unlike THC, CBD does not cause a high, making it a more acceptable option for neurological conditions beyond autism, such as epilepsy, while avoiding psychoactive effects.

In an exciting development, a Brazilian study has highlighted cannabidiol (CBD) as a potential supplement in easing autism symptoms in children and young adults. Researchers from the University of São Paulo have found that oral CBD intake led to significant improvements in social skills, reduced aggression, and eased tantrums among young participants. This promising research, presented at the 2025 European Congress of Psychiatry, suggests that CBD could be incorporated into autism treatment plans alongside traditional therapies. However, experts remain cautious, calling for larger trials to confirm these findings.